Adventures in vascular biology: a tale of two mediators
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
I would like to thank the Royal Society for inviting me to deliver the Croonian Lecture. In so doing, the Society is adding my name to a list of very distinguished scientists who, since 1738, have preceded me in this task. This is, indeed, a great honour. For most of my research career my main interest has been the understanding of the normal functioning of the blood vessel wall and the way this is affected in pathology. During this time, our knowledge of these subjects has grown to such an extent that many people now believe that the conquering of vascular disease is a real possibility in the foreseeable future. My lecture concerns the discovery of two substances, prostacyclin and nitric oxide. I would like to describe the moments of insight and some of the critical experiments that contributed significantly to the uncovering of their roles in vascular biology. The process was often adventurous, hence the title of this lecture. It is the excitement of the adventure that I would like to convey in the text that follows.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Self-citationMitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110 · cited 1×
“There are very extensive reviews on all these subjects to which the reader is referred (Moncada et al. 1991; Alderton et al. 2001; Fleming & Busse 2004).”
BackgroundEndothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839 · cited 1×
“So far, the activation of enzymes such as NADPH oxidases and xanthine oxidase has been implicated and substantial evidence now exists showing that the activity as well as the expression of these enzymes can be enhanced by pathological stimuli (see Cai & Harrison 2000; Mueller et al. 2005).”
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070 · cited 2×
“Our findings were confirmed in many laboratories and later received ‘modern’ endorsement when it was demonstrated that a model of genetic manipulation in which the endothelial NO synthase (eNOS) is knocked out exhibits a hypertensive phenotype (Huang et al. 1995) and that over-expression of eNOS in endothelial cells r…”
BackgroundResultA Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
Ridker, P. M., Cook, N. R., Lee, I.-M., Gordon, D., Gaziano, J. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050613 · Cited by 1,945
Risk of Cardiovascular Events Associated with Selective COX-2 Inhibitors
Mukherjee, D. (2001) · JAMA · doi:10.1001/jama.286.8.954 · Cited by 1,741
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
Vallance, P., Collier, J., & Moncada, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91013-1 · Cited by 1,590
Self-citationMacrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite
Hibbs, J. B., Taintor, R. R., & Vavrin, Z. (1987) · Science · doi:10.1126/science.2432665 · Cited by 1,527 · cited 16×
“Another potential source of O2 K is what has been recognized as uncoupling the NO synthase, a situation in which eNOS has the capacity to generate O2 K under the specific circumstances of low L-arginine or low BH4 (see Vasquez-Vivar et al. 1998; Stuehr et al. 2001).”
BackgroundResultInfluentialSuperoxide generation by endothelial nitric oxide synthase: The influence of cofactors
Vásquez-Vivar, J., Kalyanaraman, B., Martásek, P., Hogg, N., Masters, B. S. S., Karoui, H., Tordo, P., & Pritchard, K. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9220 · Cited by 1,484
Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide
Nisoli, E., Clementi, E., Paolucci, C., Cozzi, V., Tonello, C., Sciorati, C., Bracale, R., Valerio, A., Francolini, M., Moncada, S., et al. (2003) · Science · doi:10.1126/science.1079368 · Cited by 1,243
Self-citationCleeter, M. W. J., Cooper, J. M., Darley-Usmar, V. M., Moncada, S., & Schapira, A. H. V. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00424-2 · Cited by 1,241 · cited 1×
“…two other groups independently reported that NO inhibits the activity of the cytochrome c oxidase (complex IV), the terminal enzyme in the mitochondrial oxidative phosphorylation chain which catalyses the reduction of O2 to water (Cleeter et al. 1994; Brown & Cooper 1994; Schweizer & Richter 1994).”
BackgroundSelf-citationPlatelet Activation in Unstable Coronary Disease
Fitzgerald, D. J., Roy, L., Catella, F., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151602 · Cited by 1,141 · cited 2×
“…might be operating in vascular disease came from studies which suggested that both prostacyclin and thromboxane metabolites in urine were increased in patients with unstable angina or atherosclerosis in which platelet activation was increased (FitzGerald et al. 1984; Fitzgerald et al. 1986).”
BackgroundBrown, G. C., & Cooper, C. E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01290-3 · Cited by 1,055 · cited 2×
“Indeed, the affinity of the cytochrome c oxidase for NO is greater than that for O2, such that, for example, at 30 mM O2 (a physiological concentration of O2) the IC50 of NO is 30 nM (Brown & Cooper 1994).”
BackgroundClementi, E., Brown, G. C., Feelisch, M., & Moncada, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7631 · Cited by 863 · cited 2×
“…in NO production were also shown to inhibit cellular respiration irreversibly (Cassina & Radi 1996; Lizasoain et al. 1996) by selectively inhibiting complex I through a process dependent on the increased generation of O2 K and probably peroxynitrite (Clementi et al. 1998; Beltran et al. 2000).”
BackgroundSelf-citationAltered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773 · cited 1×
“Reprinted, with permission, from Needleman et al. (1976). Adventures in vascular biology S.”
BackgroundPoderoso, J. J., Carreras, M. C., Lisdero, C., Riobó, N., Schöpfer, F., & Boveris, A. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0146 · Cited by 726 · cited 2×
“Whether, as we and others have suggested, imbalances in this system such as high NO or low O2 are enough to initiate pathology (Poderoso et al. 1996; Beltran et al. 2000, 2002), requires further investigation.”
BackgroundRedistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α
Hagen, T., Taylor, C. T., Lam, F., & Moncada, S. (2003) · Science · doi:10.1126/science.1088805 · Cited by 704
Self-citationNitric oxide and mitochondrial respiration
Brown, G. C. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00025-0 · Cited by 702
Ascorbic Acid Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease
Levine, G. N., Frei, B., Koulouris, S. N., Gerhard, M. D., Keaney, J. F., & Vita, J. A. (1996) · Circulation · doi:10.1161/01.cir.93.6.1107 · Cited by 582 · cited 2×
“vasodilatation in both the forearm and the coronary circulation of individuals with coronary artery disease and diabetes (Levine et al. 1996; Ting et al. 1996; Solzbach et al. 1997).”
BackgroundRegulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells
Mann, G. E., Yudilevich, D. L., & Sobrevia, L. (2003) · Physiological Reviews · doi:10.1152/physrev.00022.2002 · Cited by 430
Cytochrome P450 and Vascular Homeostasis
Fleming, I. (2001) · Circulation Research · doi:10.1161/hh2101.099268 · Cited by 383
On the mechanism by which vascular endothelial cells regulate their oxygen consumption
Clementi, E., Brown, G. C., Foxwell, N., & Moncada, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1559 · Cited by 296 · cited 3×
“This suggests that NO might, on the one hand, regulate cellular bioenergetics by regulating O2 consumption (Brown 1999; Clementi et al. 1999) and on the other, by inhibiting cytochrome c oxidase, decrease electron flux through the electron transport chain and favour the generation of O2 K (Poderoso…”
BackgroundSelf-citationMechanism of action of some inhibitors of endothelium-derived relaxing factor
Moncada, S., Palmer, R. M., & Gryglewski, R. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9164 · Cited by 219 · cited 1×
“…first, that superoxide (O2 K) anions are involved in the inactivation of EDRF (Gryglewski et al. 1986b) and second, that several of the described inhibitors of EDRF were redox compounds which generated O2 K in solution and this was the mechanism by which they inhibited EDRF (Moncada et al. 1986).”
BackgroundSelf-citationGryglewski, R. J., Moncada, S., & Palmer, R. M. J. (1986) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1986.tb14586.x · Cited by 200
Self-citationCarr, A., & Frei, B. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00225-2 · Cited by 190 · cited 1×
“In relation to NO, the most often tried interventions relate to the use of antioxidants (see Carr & Frei 2000) and the manipulation of eNOS expression by genetic means (Von der Leyen & Dzau 2001).”
MethodRole of Redox Signaling in the Autonomous Proliferative Response of Endothelial Cells to Hypoxia
Schäfer, M., Schäfer, C., Ewald, N., Piper, H. M., & Noll, T. (2003) · Circulation Research · doi:10.1161/01.res.0000070882.81508.fc · Cited by 127 · cited 2×
“Specifically, it needs to be investigated whether increases in O2 K or deficiencies in its normal scavenging mechanisms might be an early step in a sequence leading to the activation of other systems that generate O2 K such as those described above (Li et al. 2001, 2003; Schafer et al. 2003).”
Background
Cited by
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology
Davies, P. F. (2009) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1397 · Cited by 1,209
The discovery of nitric oxide and its role in vascular biology
Moncada, S., & Higgs, E. A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706458 · Cited by 863
“The uncoupling of eNOS has been reported to occur in several pathological conditions such as diabetes, hypercholesterolaemia and hypertension (Cai & Harrison, 2000; Moncada, 2005).”
BackgroundMethodSelf-citationNitric Oxide and the Vascular Endothelium
Moncada, S., & Higgs, E. A. (2006) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-32967-6_7 · Cited by 408
Self-citationBirukova, A. A., Zagranichnaya, T., Fu, P., Alekseeva, E., Chen, W., Jacobson, J. R., & Birukov, K. G. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.036 · Cited by 285
Metadata
- Authors
- Moncada, S.
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2006-02-08
- Volume
- 361
- Issue
- 1469
- Pages
- 735-759
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2110829214
- Cited by
- 113
- References
- 31
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.